Context: In addition to opioids, oxygen therapy is often administered to cancer patients suffering from dyspnea before death, but there are few reports of adverse effects of this treatment. Objectives: To clarify the frequency of adverse effects of oxygen therapy for hospitalized cancer patients before death. Methods: A retrospective study of all patients who died and were discharged from the palliative care unit in Komaki City Hospital from January 2016 to June 2018 was performed. Patients to whom oxygen therapy had already been administered at the time of admission were excluded in the study. Results: The study included 257 patients, with 195 (76%) in the oxygen therapy group (O2+). The cumulative rate of oxygen therapy was 36% seven days before death, 54% three days before death, and 76% a day before death. The adverse effects included a sense of restraint for 64 cases (31%), exacerbation of delirium for 27 cases (14%), nasal/oral hemorrhage for 25 cases (13%), dryness for 5 cases (3%), and deterioration of subjective symptoms for 4 cases (2%). Along with these effects, temporary interruption of oxygen therapy was observed in 76 cases (39%). Conclusion: Oxygen therapy was started in half of the cases within 3 days before death. The adverse events to occur frequently were feeling of restriction and exacerbation of delirium.

The purposes of this study were to compare the response distribution of the result of using “nurse’s difficulty scale with cancer care” to nurses engaged in cancer nursing with 2010 survey at Tohoku University Hospital. Self-reported questionnaires were distributed to 512 nurses in 2010 and to 524 nurses in 2016. Responses from 356 (70%) nurses in 2010 and from 332 (63%) nurses in 2016 were analyzed. As a result of comparing the surveys of 2010 and 2016, the rate of correct answer in each items of the knowledge scale rose significantly (all p<0.05). From the items regarding their own knowledge and skills, difficulty in collaboration with the community, and end-of-life care decreased (both p<0.05). Despite the increase in the correct answer rate of the knowledge scale, the difficulty has become high. This may reflect the complexity in cancer care due to development of treatment.

Abstract: We report a case of acquired hemophilia A diagnosed after hospitalization in a palliative care unit. Case: The patient was an 86-year-old man diagnosed with gastric carcinoma one-year prior, who declined treatment but whose progress was being monitored. He was admitted to our hospital due to multiple, systemic, and subcutaneous bleeding and exacerbation of anemia. Blood testing revealed prolonged activated partial thromboplastin time (APTT), but the cause was unknown. Subcutaneous bleeding persisted after hospitalization, accompanied by pain. After admission to a palliative care unit, blood testing revealed only prolonged APTT; hence, a coagulation study was performed, resulting in a diagnosis of acquired hemophilia A. Immunosuppressive therapy was considered but was not performed as the patient’s progress was complicated by aspiration pneumonia for which antibiotics were ineffective, and the patient’s prognosis was determined to be short. The patient died on the 20th day after admission to the palliative care unit. Conclusion: Acquired hemophilia A is a rare hemorrhagic condition, but it is important to suspect it in cases involving prolonged APTT and spontaneous bleeding with no medical history or family history.

Objective: To review the current advance care planning (ACP) in research and clinical settings globally, and identify immediate needs in Japan. Methods: We searched reviews in MEDLINE and original articles in ICHUSHI published up to July 2019, using the Medical Subject Heading (MeSH) thesaurus term ACP; we specifically searched for papers in English or Japanese. Results: We selected 849 reviews from MEDLINE. The majority were published in the United States, and approximately 50 in the United Kingdom. We selected 2,264 articles from ICHUSHI, although 186 were original and there were few reviews. Clearly, there are far fewer ACP publications in Japan than in the US. In Japan, a common concept of ACP is not defined among researchers, medical providers, and the government for Japanese culture and social background. Furthermore, there are limited interventional ACP studies among community-dwelling people, regardless of their use of medical or long-term care services, and despite the Japanese government’s efforts to encourage ACP use. Conclusion: The concept of ACP in the Japanese culture should be identified immediately, and it is essential to provide evidence of the effectiveness of ACP among community-dwelling people. In particular, further ACP studies are needed among people provided with different kinds of home care to help support their satisfaction of end-of-life care, which is a part of community integrated care.